And we can continue moving toward better metabolic health with a plan built around preservation of lean mass and long-term outcomes
Tirzepatide generally produces greater average weight loss in clinical trials, with the SURMOUNT-1 trial showing up to 22.5% body weight reduction at the highest dose compared to semaglutide roughly 15-17% in comparable trials
By seeking clarity on these aspects, you equip yourself with the knowledge needed to make well-informed choices that support a healthy pregnancy journey
When You Experience Other Concerning Symptoms In addition to diarrhea, there are other symptoms that, when paired with digestive issues, should prompt a visit to your healthcare provider
Whether that advantage holds in broader populations, across longer treatment periods, and with varying compliance patterns remains an open question
If no weight loss appears by week 4, your dose may need adjustmentcontact your provider